Mirae Asset Global Investments »

Entrada Therapeutics shares owned by Mirae Asset Global Investments

Quarter-by-quarter ownership of Entrada Therapeutics (TRDA) shares owned by Mirae Asset Global Investments from 13F filings

Historical chart of Mirae Asset Global Investments investment in Entrada Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Entrada Therapeutics held by Mirae Asset Global Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Entrada Therapeutics by Mirae Asset Global Investments

Quarter filed Position value Share count Share price at filing
2023-12-31 $164k 11k 15.09
2023-09-30 $172k 11k 15.80
2023-06-30 $165k 11k 15.14